252 Pill - white round
Pill with imprint 252 is White, Round and has been identified as Pramipexole Dihydrochloride Extended-Release 0.75 mg. It is supplied by Par Pharmaceutical Inc.
Pramipexole is used in the treatment of Restless Legs Syndrome; Periodic Limb Movement Disorder; Parkinson's Disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 0.75 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 252
Pramipexole Dihydrochloride Extended-Release
- Imprint
- 252
- Strength
- 0.75 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Par Pharmaceutical Inc
- Inactive Ingredients
-
hypromelloses,
corn starch,
silicon dioxide,
D&C Yellow No. 10,
hydrogenated cottonseed oil,
hydroxypropyl cellulose,
magnesium stearate,
mannitol,
microcrystalline cellulose,
titanium dioxide,
magnesium silicate,
soya lecithin,
xanthan gum
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 10370-0252 (Discontinued) | Anchen Pharmaceuticals, Inc. |
| 42291-0554 (Discontinued) | AvKare, Inc. |
Related images for "252"
More about pramipexole
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (234)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: dopaminergic antiparkinsonism agents
- Breastfeeding
- En español
Patient resources
- Pramipexole drug information
- Pramipexole (Advanced Reading)
- Pramipexole Extended-Release Tablets
- Pramipexole Tablets
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
